Bosh sahifaPLX • NYSEAMERICAN
add
Protalix Biotherapeutics Inc
2,19 $
Seans yopilganidan keyin:(2,66%)+0,058
2,25 $
Yopilgan:1-apr, 16:35:01 (GMT-4) · USD · NYSEAMERICAN · Ogohlantirish
Yopilish kursi
2,19 $
Kunlik diapazon
2,17 $ - 2,26 $
Yillik diapazon
1,32 $ - 3,19 $
Bozor kapitalizatsiyasi
176,45 mln USD
Oʻrtacha hajm
1,22 mln
Narx/foyda
-
Dividend daromadliligi
-
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 9,12 mln | -49,93% |
Joriy xarajat | -9,73 mln | -85,01% |
Sof foyda | -5,50 mln | -184,76% |
Sof foyda marjasi | -60,34 | -269,26% |
Har bir ulushga tushum | — | — |
EBITDA | -4,27 mln | -156,62% |
Amaldagi soliq stavkasi | -15,24% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 30,27 mln | -13,08% |
Jami aktivlari | 82,35 mln | 12,16% |
Jami passivlari | 34,12 mln | 12,94% |
Umumiy kapital | 48,23 mln | — |
Tarqatilgan aksiyalar | 80,57 mln | — |
Narxi/balansdagi bahosi | 3,64 | — |
Aktivlardan daromad | -14,15% | — |
Kapitaldan daromad | -19,80% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -5,50 mln | -184,76% |
Operatsiyalardan naqd pul | 2,03 mln | -49,14% |
Sarmoyadan naqd pul | -1,11 mln | 92,74% |
Moliyadan naqd pul | 146,00 ming | -95,97% |
Naqd pulning sof oʻzgarishi | 1,03 mln | 113,51% |
Boʻsh pul | 2,88 mln | 72,67% |
Haqida
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. Wikipedia
CEO
Tashkil etilgan
1993
Bosh ofis
Sayt
Xodimlar soni
226
